GT Medical Technologies’ implant delivers radiation therapy directly to the bed of an excised brain tumor—a potential game-changer for people with highly proliferative, hard-to-treat tumors such as glioblastomas. Its GammaTile Therapy is now in use at 75 US hospitals and the firm has raised $26 million over the past three years—not bad for a company that launched its flagship product at the height of the pandemic.
GT Medical announced the first participant enrolled in the GammaTile Enhanced Stupp ALTernative (GESTALT) trial. While this trial is still in its infancy, if the results are favorable, it may influence protocols for treating glioblastomas (GBMs) and bridge the gap between surgery and chemoradiation.
Doctors at UofL Health are the first in the state to use a new brain cancer radiation treatment called the gamma tile.
GT Medical Technologies’ GammaTile is a surgically targeted radiation therapy (STaRT) for brain tumors. GT Medical Technologies designed the GammaTile to provide immediate, dose-intense treatment at the completion of resection. The company says the therapy system can extend local recurrence-free survival with minimal complications to reduce patient burden and assure compliance.
Today is Glioblastoma Awareness Day
Posted at 5:54 PM, Jul 20, 2022 and last updated 5:54 PM, Jul 20, 2022
Today is Glioblastoma Awareness Day, a day to help those affected by this devastating disease and remember lives lost to Glioblastoma (GMB), lives like Senator John McCain, and Mike Traphagen.
A once-discarded approach to radiation therapy for brain tumors has re-emerged as a solid secondary treatment for refractory disease. Surgically targeted radiation therapy (STaRT),a form of Cesium-131 brachytherapy, is now …
GT has a number of advantages. Unlike with traditional brachytherapy, the collagen tile provides a buffer around the radiation sources, allowing delivery of the optimal radiation dose while preserving healthy tissue.
A diagnosis of cancer is shocking for most people. But a diagnosis of brain cancer may carry additional fear when one considers these facts: no other cancer is as challenging to effectively treat as brain cancer, and the average five-year survival rate for people with malignant brain tumors is about 36%.
Fortunately, the availability of a novel treatment called GammaTile® Therapy is offering hope for people like 68-year-old Jane Finch Hall.
Saint Alphonsus doctors are now the first in the Northwest to use GammaTile–a radiation therapy treatment for brain tumors.
The FDA-cleared treatment surgically implants postage-stamp-sized tiles which provide radiation over the course of 33 days and then disintegrate.
Mayfield Brain & Spine’s Vincent DiNapoli, M.D., Ph.D. was the first surgeon in the eastern U.S. to perform surgery on recurrent brain tumors using a new radiation delivery technique called GammaTile Therapy. Now, he’s partnered with Oncology Hematology Care and Jewish Hospital – Mercy Health (where he’s also the director of the Brain Tumor Center) for a new study using GammaTile to treat newly diagnosed primary cancer that’s moved to the brain. DiNapoli explains how the treatment works.
